nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—GUCY1B3—tongue—Parkinson's disease	0.0297	0.0934	CbGeAlD
Nitric Oxide—GUCY1B3—forebrain—Parkinson's disease	0.0126	0.0396	CbGeAlD
Nitric Oxide—GUCY1A2—head—Parkinson's disease	0.0115	0.0363	CbGeAlD
Nitric Oxide—GUCY1A2—nervous system—Parkinson's disease	0.0109	0.0344	CbGeAlD
Nitric Oxide—GUCY1A3—cardiovascular system—Parkinson's disease	0.0107	0.0337	CbGeAlD
Nitric Oxide—ALDH2—forebrain—Parkinson's disease	0.0107	0.0336	CbGeAlD
Nitric Oxide—GUCY1B3—cardiovascular system—Parkinson's disease	0.0106	0.0335	CbGeAlD
Nitric Oxide—GUCY1A2—central nervous system—Parkinson's disease	0.0105	0.0331	CbGeAlD
Nitric Oxide—GUCY1A2—cerebellum—Parkinson's disease	0.0103	0.0324	CbGeAlD
Nitric Oxide—GUCY1A3—medulla oblongata—Parkinson's disease	0.00916	0.0288	CbGeAlD
Nitric Oxide—GUCY1B3—medulla oblongata—Parkinson's disease	0.00909	0.0286	CbGeAlD
Nitric Oxide—ALDH2—cardiovascular system—Parkinson's disease	0.00903	0.0284	CbGeAlD
Nitric Oxide—GUCY1A3—midbrain—Parkinson's disease	0.00837	0.0263	CbGeAlD
Nitric Oxide—GUCY1A2—brain—Parkinson's disease	0.00835	0.0263	CbGeAlD
Nitric Oxide—GUCY1B3—midbrain—Parkinson's disease	0.00831	0.0262	CbGeAlD
Nitric Oxide—GUCY1A3—spinal cord—Parkinson's disease	0.00816	0.0257	CbGeAlD
Nitric Oxide—GUCY1B3—spinal cord—Parkinson's disease	0.0081	0.0255	CbGeAlD
Nitric Oxide—ALDH2—medulla oblongata—Parkinson's disease	0.00772	0.0243	CbGeAlD
Nitric Oxide—GUCY1A3—head—Parkinson's disease	0.00726	0.0228	CbGeAlD
Nitric Oxide—GUCY1B3—head—Parkinson's disease	0.0072	0.0227	CbGeAlD
Nitric Oxide—ALDH2—midbrain—Parkinson's disease	0.00705	0.0222	CbGeAlD
Nitric Oxide—ALDH2—spinal cord—Parkinson's disease	0.00688	0.0217	CbGeAlD
Nitric Oxide—GUCY1A3—nervous system—Parkinson's disease	0.00688	0.0217	CbGeAlD
Nitric Oxide—GUCY1B3—nervous system—Parkinson's disease	0.00683	0.0215	CbGeAlD
Nitric Oxide—GUCY1A3—central nervous system—Parkinson's disease	0.00662	0.0209	CbGeAlD
Nitric Oxide—GUCY1B3—central nervous system—Parkinson's disease	0.00658	0.0207	CbGeAlD
Nitric Oxide—GUCY1A3—cerebellum—Parkinson's disease	0.00647	0.0204	CbGeAlD
Nitric Oxide—GUCY1B3—cerebellum—Parkinson's disease	0.00643	0.0202	CbGeAlD
Nitric Oxide—ALDH2—head—Parkinson's disease	0.00612	0.0193	CbGeAlD
Nitric Oxide—ALDH2—nervous system—Parkinson's disease	0.0058	0.0183	CbGeAlD
Nitric Oxide—ALDH2—central nervous system—Parkinson's disease	0.00558	0.0176	CbGeAlD
Nitric Oxide—ALDH2—cerebellum—Parkinson's disease	0.00546	0.0172	CbGeAlD
Nitric Oxide—GUCY1A3—brain—Parkinson's disease	0.00526	0.0166	CbGeAlD
Nitric Oxide—GUCY1B3—brain—Parkinson's disease	0.00522	0.0164	CbGeAlD
Nitric Oxide—ALDH2—brain—Parkinson's disease	0.00443	0.014	CbGeAlD
Nitric Oxide—CYP2B6—cardiovascular system—Parkinson's disease	0.00405	0.0128	CbGeAlD
Nitric Oxide—CYP2B6—head—Parkinson's disease	0.00274	0.00864	CbGeAlD
Nitric Oxide—CYP2B6—nervous system—Parkinson's disease	0.0026	0.00819	CbGeAlD
Nitric Oxide—CYP2B6—central nervous system—Parkinson's disease	0.00251	0.00789	CbGeAlD
Nitric Oxide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00219	0.00321	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—CHRNA4—Parkinson's disease	0.00217	0.00318	CbGpPWpGaD
Nitric Oxide—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00216	0.00316	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00214	0.00313	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00213	0.00312	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00206	0.00301	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—GSTM1—Parkinson's disease	0.00206	0.00301	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—FGB—Parkinson's disease	0.00202	0.00296	CbGpPWpGaD
Nitric Oxide—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.002	0.00293	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00199	0.00292	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00199	0.00292	CbGpPWpGaD
Nitric Oxide—CYP2B6—brain—Parkinson's disease	0.00199	0.00626	CbGeAlD
Nitric Oxide—ALDH2—Neuronal System—HSPA8—Parkinson's disease	0.00199	0.00291	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00198	0.0029	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00197	0.00289	CbGpPWpGaD
Nitric Oxide—CYP3A4—nervous system—Parkinson's disease	0.00197	0.00619	CbGeAlD
Nitric Oxide—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00196	0.00287	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00193	0.00282	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00192	0.00282	CbGpPWpGaD
Nitric Oxide—CYP3A4—central nervous system—Parkinson's disease	0.00189	0.00596	CbGeAlD
Nitric Oxide—ALDH2—Neuronal System—DLG4—Parkinson's disease	0.00186	0.00273	CbGpPWpGaD
Nitric Oxide—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00183	0.00268	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00183	0.00268	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—GRIN2B—Parkinson's disease	0.00182	0.00267	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—Parkinson's disease	0.00182	0.00267	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0018	0.00264	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—SLC6A3—Parkinson's disease	0.0018	0.00263	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00179	0.00263	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00176	0.00258	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SOD1—Parkinson's disease	0.00168	0.00247	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SOD1—Parkinson's disease	0.00168	0.00247	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00167	0.00245	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00165	0.00242	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00165	0.00242	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00164	0.00241	CbGpPWpGaD
Nitric Oxide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00163	0.00238	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—ABL1—Parkinson's disease	0.00161	0.00235	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—ABL1—Parkinson's disease	0.00161	0.00235	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IGF2—Parkinson's disease	0.0016	0.00234	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IGF2—Parkinson's disease	0.0016	0.00234	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00155	0.00227	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—COMT—Parkinson's disease	0.00153	0.00224	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—MAOA—Parkinson's disease	0.00152	0.00222	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—HGF—Parkinson's disease	0.00151	0.00221	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—HGF—Parkinson's disease	0.00151	0.00221	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00151	0.00221	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SOD1—Parkinson's disease	0.0015	0.0022	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00148	0.00217	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ND3—Parkinson's disease	0.00146	0.00214	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MCCC1—Parkinson's disease	0.00146	0.00214	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00145	0.00212	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—ABL1—Parkinson's disease	0.00143	0.0021	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IGF2—Parkinson's disease	0.00143	0.00209	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00138	0.00203	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TALDO1—Parkinson's disease	0.00137	0.00201	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—OMD—Parkinson's disease	0.00137	0.00201	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00136	0.00199	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00135	0.00198	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—HGF—Parkinson's disease	0.00135	0.00197	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NDUFB11—Parkinson's disease	0.0013	0.0019	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GCH1—Parkinson's disease	0.00124	0.00182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00122	0.00179	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00121	0.00177	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.0012	0.00177	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.0012	0.00177	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0012	0.00175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.0012	0.00175	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTA4—Parkinson's disease	0.00119	0.00174	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00117	0.00172	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00117	0.00172	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00112	0.00163	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GBA—Parkinson's disease	0.0011	0.00162	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—FBP1—Parkinson's disease	0.0011	0.00162	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—DBH—Parkinson's disease	0.0011	0.00162	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.0011	0.00161	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00108	0.00158	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	0.00107	0.00156	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00106	0.00156	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—MAOB—Parkinson's disease	0.00106	0.00155	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000985	0.00144	CbGpPWpGaD
Nitric Oxide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000981	0.00144	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000972	0.00142	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00094	0.00138	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000935	0.00137	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000906	0.00133	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000873	0.00128	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000831	0.00122	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000827	0.00121	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00082	0.0012	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—DDC—Parkinson's disease	0.000811	0.00119	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000798	0.00117	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	0.000788	0.00115	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000777	0.00114	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTA4—Parkinson's disease	0.000766	0.00112	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00076	0.00111	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00075	0.0011	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	0.00072	0.00106	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00071	0.00104	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.0007	0.00103	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00069	0.00101	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PLA2G6—Parkinson's disease	0.00069	0.00101	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MAOB—Parkinson's disease	0.000683	0.001	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000674	0.000987	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000657	0.000963	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000624	0.000914	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000616	0.000903	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000601	0.00088	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000598	0.000876	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—COMT—Parkinson's disease	0.000597	0.000875	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	0.000594	0.00087	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	0.000593	0.000868	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	0.000589	0.000863	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000586	0.000859	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000549	0.000805	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000546	0.0008	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00054	0.000792	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000538	0.000789	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000533	0.000781	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP2D6—Parkinson's disease	0.000507	0.000743	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000507	0.000743	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CTGF—Parkinson's disease	0.000498	0.00073	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000484	0.00071	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000482	0.000706	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP2E1—Parkinson's disease	0.000464	0.00068	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000464	0.00068	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NQO1—Parkinson's disease	0.000459	0.000672	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000457	0.00067	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TH—Parkinson's disease	0.000452	0.000663	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYCS—Parkinson's disease	0.000434	0.000636	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000424	0.000621	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000418	0.000613	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000388	0.000568	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ND3—Parkinson's disease	0.000387	0.000567	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MCCC1—Parkinson's disease	0.000387	0.000567	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—COMT—Parkinson's disease	0.000384	0.000563	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—Parkinson's disease	0.000383	0.000561	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MAOA—Parkinson's disease	0.000382	0.000559	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—HMOX1—Parkinson's disease	0.000377	0.000553	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TALDO1—Parkinson's disease	0.000364	0.000533	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—OMD—Parkinson's disease	0.000364	0.000533	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ABCB1—Parkinson's disease	0.000362	0.000531	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000358	0.000524	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000353	0.000517	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTM1—Parkinson's disease	0.000352	0.000515	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000351	0.000515	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000351	0.000515	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000351	0.000515	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00035	0.000513	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000349	0.000511	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000347	0.000508	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	0.000345	0.000506	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000345	0.000505	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPX1—Parkinson's disease	0.000337	0.000493	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GCH1—Parkinson's disease	0.000329	0.000482	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000327	0.00048	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000323	0.000473	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000321	0.000471	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000317	0.000465	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MTHFR—Parkinson's disease	0.000311	0.000455	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—FBP1—Parkinson's disease	0.000293	0.00043	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GBA—Parkinson's disease	0.000293	0.00043	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—DBH—Parkinson's disease	0.000293	0.00043	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—APOE—Parkinson's disease	0.000289	0.000424	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000271	0.000397	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.00027	0.000396	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000269	0.000395	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000267	0.000392	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000266	0.00039	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000248	0.000363	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—INS—Parkinson's disease	0.000247	0.000362	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000245	0.000359	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000242	0.000355	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000228	0.000334	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000228	0.000334	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—DDC—Parkinson's disease	0.000215	0.000315	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000214	0.000314	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000214	0.000314	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTA4—Parkinson's disease	0.000203	0.000298	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000203	0.000298	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000194	0.000284	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	0.000183	0.000268	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MAOB—Parkinson's disease	0.000181	0.000266	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000176	0.000258	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000176	0.000258	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000175	0.000256	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000173	0.000253	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000173	0.000253	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000173	0.000253	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000165	0.000242	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000165	0.000242	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000157	0.00023	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.00015	0.000219	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	0.000135	0.000197	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000133	0.000195	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000133	0.000195	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000133	0.000195	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CTGF—Parkinson's disease	0.000132	0.000194	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000127	0.000186	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	0.000123	0.000181	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NQO1—Parkinson's disease	0.000122	0.000178	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TH—Parkinson's disease	0.00012	0.000176	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.00012	0.000175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000118	0.000173	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYCS—Parkinson's disease	0.000115	0.000169	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000108	0.000158	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000107	0.000156	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—COMT—Parkinson's disease	0.000102	0.00015	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—Parkinson's disease	0.000102	0.000149	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000102	0.000149	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MAOA—Parkinson's disease	0.000101	0.000149	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—HMOX1—Parkinson's disease	0.0001	0.000147	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—DDC—Parkinson's disease	9.78e-05	0.000143	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ABCB1—Parkinson's disease	9.62e-05	0.000141	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTM1—Parkinson's disease	9.34e-05	0.000137	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.24e-05	0.000135	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPX1—Parkinson's disease	8.94e-05	0.000131	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.32e-05	0.000122	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MTHFR—Parkinson's disease	8.25e-05	0.000121	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.23e-05	0.000121	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	7.93e-05	0.000116	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CTGF—Parkinson's disease	7.78e-05	0.000114	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—APOE—Parkinson's disease	7.68e-05	0.000113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	7.25e-05	0.000106	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NQO1—Parkinson's disease	7.17e-05	0.000105	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TH—Parkinson's disease	7.07e-05	0.000104	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYCS—Parkinson's disease	6.79e-05	9.94e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—INS—Parkinson's disease	6.56e-05	9.62e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.12e-05	8.97e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—COMT—Parkinson's disease	6.01e-05	8.81e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.01e-05	8.8e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.98e-05	8.77e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.97e-05	8.74e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HMOX1—Parkinson's disease	5.9e-05	8.64e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.66e-05	8.3e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.6e-05	8.2e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.53e-05	8.11e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.5e-05	8.05e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TH—Parkinson's disease	5.45e-05	7.99e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.26e-05	7.71e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.24e-05	7.67e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.86e-05	7.12e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—COMT—Parkinson's disease	4.64e-05	6.8e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.62e-05	6.76e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.61e-05	6.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.55e-05	6.67e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—APOE—Parkinson's disease	4.52e-05	6.63e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.37e-05	6.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.24e-05	6.22e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.06e-05	5.95e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—INS—Parkinson's disease	3.86e-05	5.66e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.75e-05	5.49e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—APOE—Parkinson's disease	3.49e-05	5.11e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—INS—Parkinson's disease	2.98e-05	4.37e-05	CbGpPWpGaD
